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We have shown that epoxyeicosatrienoic acids (EETs), specifically 11,12- and 14,15-EETs, reduce
adipogenesis in human mesenchymal stem cells and mouse preadipocytes (3T-3L1). In this study,
we explore the effects of soluble epoxide hydrolase (sEH) deletion on various aspects of
adipocyte-function, including programing for white vs. beige-like fat, and mitochondrial and
thermogenic gene-expressions. We further hypothesize that EETs and heme-oxygenase 1 (HO-1)
form a synergistic, functional module whose effects on adipocyte and vascular function is greater
than the effects of sEH deletion alone. In in vitro studies, we examined the effect of sEH inhibitors
on MSC-derived adipocytes. MSC-derived adipocytes exposed to AUDA, an inhibitor of sEH,
exhibit an increased number of small and healthy adipocytes, an effect reproduced by siRNA for
sEH. in vivo studies indicate that sEH deletion results in a significant decrease in adipocyte size,
inflammatory adipokines NOV, TNFα, while increasing adiponectin (p < 0.05). These findings are
associated with a decrease in body weight (p < 0.05), and visceral fat (p < 0.05). Importantly, sEH
deletion was associated with a significant increase in Mfn1, COX 1, UCP1 and adiponectin (p <
0.03). sEH deletion was manifested by a significant increase in EETs isomers 5,6-EET, 8,9-EET,
11,12-EET, and 14,15-EET and an increased EETs/DHETEs ratio. Notably, activation of HO-1
gene expression further increased the levels of EETs, suggesting that the antioxidant HO-1 system
protects EETs from degradation by ROS. These results are novel in that sEH deletion, while
increasing EET levels, resulted in reprograming of white fat to express mitochondrial and
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thermogenic genes, a phenotype characteristic of beige-fat. Thus, EETs agonist(s) and sEH
inhibitors may have therapeutic potential in the treatment of metabolic syndrome and obesity.

Keywords
Heme Oxygenase; PGC-1 coactivators; Oxidative phosphorylation; Uncoupling protein 1 (UCP1);
Mitochondrial protein

1.

Introduction

Author Manuscript

Metabolic disorders, such as obesity, diabetes, hypertension and cardiovascular disease, have
become more of an epidemic in recent years. Obesity is characterized by a pathological
increase in white fat, associated with high levels of inflammation, insulin resistance and
mitochondrial dysfunction, contributing to diabetes, hypertension and even heart failure [1].
Several studies indicate that browning of white fat can ameliorate obesity and associated
metabolic disorders [2]. Beige and brown fat, which contains small adipocytes, dissipate
energy as heat, resulting in the burning of calories and a potential weight loss in mice and
humans [3,4]. Therefore, increasing thermogenic genes and mitochondrial function could
result in the transformation of white-fat to beige-fat.

Author Manuscript

Adipose tissue function is controlled by several processes including mitochondrial
biogenesis and adaptive thermogenesis, highlighting the essential role of mitochondrial
function in adipocytes. Adipocyte mitochondria are deficient in insulin-resistant individuals
and correlate with systemic lipid metabolism, inflammation and insulin sensitivity [5]. The
function of the mitochondrial network depends on quality control, referred to fusion and
fission. Mitofusin 1 and 2 (Mfn1 and Mfn2) facilitate the mitochondrial fusion process [6]
while COX-1 is related to mitochondrial oxidative phosphorylation (OXPHOS) [7]. Brown
adipose tissue generates heat by uncoupling respiration with its unique mitochondrial
membrane embedded protein UCP1, a process known as non-shivering thermogenesis [8],
which increases heat production through an uncoupling of oxidative metabolism from ATP
production [9].
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Epoxyeicosatrienoic acids (EETs) are arachidonic acid derived lipid mediators with
beneficial effects on metabolic and cardiovascular health [10]. EETs are derived from
arachidonic acid by a CYP pathway, predominately mammalian CYP epoxygenases,
resulting in four separate regioisomers of EETs [11]. EETs are rapidly degraded by soluble
epoxide hydrolase (sEH), which exists in mammalian tissues, including the myocardium,
kidney, liver, adipose and blood vessels [12]. sEH is known to play a pro-inflammatory role
during inflammation by metabolizing EETs to DHETs [13]. This results in the degradation
of endogenous anti-inflammatory EET’s. Our recent research indicated that EETs
upregulates the heme-HO system [3,14,15], mitochondrial function, as well as
thermogenesis which have a profound effect on improving adipocyte function [16]. The HO
system represents an important protective mechanisim in the cardiovascular and metabolic
system(s) against the harmful effects of oxidative stress [17,18].
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Clinical studies have shown that sEH gene polymorphism is associated with insulin
resistance (IR) [19], and IR is the one of the key features in obesity. IR is accompanied by
increased reactive oxygen species (ROS) in adipocytes, release of a series of redox and
inflammatory mediators, and creation of large, dysfunctional adipocytes [20].
Overexpression of sEH in non-diabetic mice resulted in similar vessel abnormalities as
diabetic mice with retinopathy [21]; whereas, inhibition of sEH suppressed inflammation in
cardiovascular disease [22]. Recently, we have shown that upregulation of EETs can
increases HO-1 expression; leading to a reduction in fatty acid synthesis, conversion of large
adipocytes to small adipocytes and a decrease in body weight [23].

Author Manuscript

In our present study, we explored the relationship of sEH-inhibition and mitochondrial geneexpression with regard to genes involved in thermogenesis. We have also examined the
functional EET-HO-1 module and its effects, if any, on EET production and phenotype of
sEH knockout mice. Our results demonstrate that sEH knockdown augments the prothermogenic profile of adipose tissue mitochondria with significantly reduced adipose tissue
burden, effects further accentuated by HO-1-induction.

2.
2.1.

Methods
Differentiation of human bone marrow-derived MSCs into adipocytes

Author Manuscript

Frozen bone marrow mononuclear cells were purchased from Allcells (Allcells, Emeryville,
CA, USA). After thawing, mononuclear cells were re-suspended in a-minimal essential
medium (a-MEM, Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Invitrogen) and 1% antibiotic/antimycotic solution
(Invitrogen). The cells were plated at a density of 1 to 5 × 10 [6] cells per 100-cm2 dish. The
medium was replaced with adipogenic medium, and the cells were cultured for an additional
14 days as described previously [24]. The cells were treated with 11, 12-EET and 14, 15EET (1 μM) alone and with sEH inhibitor (AUDA) (1 μM), or with sEH siRNA using an NTER kit (Sigma-Aldrich, St. Louis, MO) according to manufacturer’s protocol.
2.2.

Oil Red O staining
For Oil Red O staining, 0.21% Oil Red O in 100% isopropanol (Sigma-Aldrich, St. Louis,
MO) was used. Briefly, adipocytes were fixed in 10% formaldehyde, stained in Oil red O for
10 min, rinsed with 60% isopropanol (Sigma–Aldrich, St. Louis, MO), and the Oil red O
eluted by adding 100% isopropanol for 10 min and OD measured at 490 nm.

2.3.

Animal protocols

Author Manuscript

Male sEH null mice were provided by Dr. Darryl C. Zeldin at age of 12 weeks. Agedmatched B6129SF2/J mice served as controls. Mice were fed a normal chow diet and had
free access to water, no difference in food intake was observed between different groups. All
mice were divided in to 3 groups; 1) Control; 2) sEH KO male mice; 3) sEH KO + CoPP
male mice. Cobalt protoporphyrin IX (CoPP) (3 mg/kg once a week) was administered i.p.
for 8 weeks. Measurement of body weight was made during the course of the study. At
sacrifice, aorta and adipocyte tissues were immediately collected, weighed and stored at
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−80 °C until use. The Animal Care and Use Committee of New York Medical College
approved all experiments.
2.4.

RNA, protein signaling, and EET measurement
After collecting all the samples, we use RT-PCR to measure gene expression in both cells
and tissue. Total RNA was isolated using Trizol® (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions [23,25]. Protein signals were measured as previously
described [14]. EETs were extracted using solid phase C18-ODS AccuBond II 500-mg
cartridges, where after EET levels were analyzed by LC–MS/MS as described [26].

2.5.

Measurement of superoxide in aorta tissues

Author Manuscript

Samples were placed in scintillation mini vials containing 5 mm of lucigenin and 1 ml of
Krebs solution buffered (pH 7.4). Lucigenin chemiluminescence was measured in a liquid
scintillation counter (LS6000IC; Beckman Instruments, San Diego, CA) at 37 °C; data are
reported as counts/min/mg protein after background subtraction.
2.6.

Statistical analysis
All values are presented as mean ± SE. Statistical significance between experimental groups
was determined by the Fisher method of analysis of multiple comparisons (p < 0.05). For
comparison between treatment groups, the null hypothesis was tested by a single-factor
ANOVA for multiple groups or unpaired t-test for two groups, p < 0.05 was regarded as
significant.

3.

Results

Author Manuscript

3.1. Effect of EETs and sEH inhibition on oil droplet formation in MSCs derived
adipocytes
To elucidate the role of EETs in the regulation of adipogenesis during MSCs differentiation
to adipocyte lineage, we measured the effect of EETs administration and suppression of sEH
on adipogenesis. Daily supplementation of 11, 12-, and 14, 15-EETs was effective on
adipogenesis suppression at 14 days. Inhibition of sEH with AUDA, showed a significant (p
< 0.05) and synergistic reduction of lipid droplet formation in MSC-derived adipocytes (Fig.
1).
3.2.

Effect of sEH deletion on oil droplet formation

Author Manuscript

As shown in Fig. 2, ablation of sEH significantly (p < 0.05) decreased lipid droplets size in
MSC derived adipocytes. The percentage of cells with morphological lipid droplets
decreased following silencing of sEH. The adipocyte cell size in the absence of siRNA was
± pixels compared with ± pixels in the presence of siRNA (Fig. 2).
3.3.

Effect of sEH knockout on Inflammatory Cytokine levels in adipose tissue
RT_PCR analysis showed a significant (p < 0.05) increase in HO-1 mRNA expression in
adipose tissue of sEH KO mice as compared to WT control mice (Fig. 3A), the mRNA
expression of inflammatory cytokines such as NOV and TNFα were significantly (p < 0.05)
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lower in sEH KO mice compared to control (Fig. 3B and 3C), These results indicate that
deletion of sEH leads to HO-1 induction resulting in a decrease of inflammation.
3.4.

Effect of sEH knockout on mitochondrial function and thermogenic genes

Author Manuscript

Mitochondrial fusion is essential for mitochondrial function, therefore, to examine whether
sEH can modulate the mitochondrial fusion-to-fission ratio, we measured Mfn1 and Mfn2
levels in adipose tissue of sEH KO mice. There was a significant (p < 0.05) increase in Mfn1
mRNA expression in sEH KO mice compared to control. However, there was no significant
change in Mfn2 expression (Fig. 3D and E). Furthermore, levels of cytochrome c oxidase
subunit I (COX-I) were significantly (p < 0.05) higher in KO mice (Fig. 3F), and expression
of FIS1 was not significantly different between groups (Fig. 3G). Our analysis demonstrated
that UCP1 mRNA expression levels were significantly increased in sEH KO mice compared
to control mice (Fig. 3H). Moreover, adiponectin mRNA expression significantly increased
(p < 0.05) in sEH KO mice (Fig. 3I).
In agreement with results from fat tissue, we observed a significant (p < 0.05) increase in
Mfn1 (Fig. 4A) as well as in HO-1 (Fig. 4B) expression in the aortas of sEH KO mice as
compared to control. These results indicate that deletion of sEH resulted in an increase in
mitochondrial function. To investigate the effect of sEH deletion on lipid metabolism, we
analyzed the expression of thermogenic markers which characterize brown adipocytes.
3.5.

Effect of sEH ablation and HO-1 induction on superoxide formation
Ablation of sEH and HO-1 induction significantly (p < 0.05) reduced superoxide anion
formation in aortas of mice compared to both KO sEH and WT control (Fig. 4C).

Author Manuscript

3.6.

Effect of sEH ablation with and without HO-1 Inducer on adiposity
As seen in Fig. 5, deletion of sEH decreased body weight in male null mice compared to
control. Pictures of mice indicate that sEH KO mice are leaner than the control group (Fig.
5A). Body weight of KO mice was 28.8 ± 7.28 g compared with 36.17 ± 0.77 g in control
mice (Fig. 5B). To further increase the antioxidant functions of EETs, we treated sEH KO
mice with a well-known HO-1 inducer cobalt Protoporphyrin (CoPP) an inducer of HO-1.
Western blot analysis showed a significant (p < 0.05) increase in HO-1 protein expression in
adipose tissue of sEH KO mice as compared to WT control mice, this increase was even
more significant when CoPP was administered to sEH KO mice (Fig. 5C). The body weight
in sEH null mice was similar to the sEH + CoPP group.

3.7.

Effect of sEH ablation and HO-1 induction on EETs levels

Author Manuscript

The levels of isoforms of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) and that total
EETs (2.32 ± 0.22 mg vs. 0.61 ± 0.06 mg) were significantly (p < 0.05) increased in sEH
KO mice compared to control mice. Since not all EETs are released as functional EETs, we
administered CoPP to sEH KO mice. As a result, there was a significant increase in all forms
of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) as well as of total EETs levels
compared to control mice and sEH KO without CoPP treatment (Fig. 6A–F).
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Discussion
This study demonstrates that EETs improve adipocyte structure and function via
upregulation of mitochondrial thermogenic genes, and restore redox and inflammatory
balance in adipose tissues. We also establish the operational nature of the HO-EET
synergistic module by demonstrating elevated EET levels in sEH KO mice treated with
CoPP and by an improved phenotype in these mice (Fig. 7).
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The first key finding of the study is the rescue of adipocyte function by sEH inhibitors and
knockdowns. Our results demonstrates that the production of the pro-inflammatory
adipokine, NOV, is attenuated by sEH deletion as well as by increased levels of HO-1. We
also found that the level of mitochondrial signaling; Mfn1 increased in sEH KO mice.
Furthermore, there was an increase of COX-1 in the adipose tissue of KO mice indicating
that sEH deletion and increases of EET levels plays a crucial role in mitochondrial integrity
and fat phonotype (Fig. 7). Previous studies indicate that HO-1 induction decreases ROS
formation as well as controls adiposity in transgenic mice [27]. In our current study we
showed that increasing EETs through inhibition of sEH leads to diminished MSC-derived
adipocyte terminal differentiation, decreased lipid droplet formation and inhibition of
adipogenesis. In agreement with published reports [28–30], increase of EET as result of
inhibition of sEH in adipocytes can turn large unhealthy adipocytes into small healthy
adipocytes. In fact levels of EET in pre = adipocyte is higher than EET Levels in fully
mature adipocyte [24,30]. This is further strengthened by the fact that inhibition of sEH
increases thermogenic genes; UCP1 expression, suggesting a transformation of white fat to
beige or brown fat.

Author Manuscript
Author Manuscript

The second key finding of this study derives from our in vivo experiments where we found
that ablation of sEH decreased the degradation of EETs leading to increased antioxidants,
anti-inflammatory and lipid lowering effects, as well as the body size and weight reduction
of sEH KO mice, both with and without treatment with CoPP, an inducers of HO-1. HO-1
induction increased EET which led to weight loss and decreased fat deposition. The results
regarding adipose tissue loss and reduced body weight in sEH null mice and associated
increases in total EET-levels are confirmed by our previous studies with total body MRI in
which reduction of adipose tissue was confirmed [31–33]. We do not know why increased
levels of HO-1 by CoPP administration did not result in any additional weight loss, possibly
the mice reached the lowest level of fat so that additional weight loss was not possible.
Obesity and metabolic syndrome, characterized by body weight gain, low level
inflammation and oxidative stress overexpression, is associated with hyperlipidemia, insulin
resistance and cardiovascular diseases [1]. Recent research indicated that white fat increased
in obesity and was accompanied with inflammation [1,18,28,34]. the amelioration of renal
inflammation will reduce hypertension and type II diabetes [35]. A chronic high fat diet
increased expression of adipose sEH protein in mice [36], this could be translated to humans
where adipose sEH expression is increabetes and obesity-induced cardiovasc sed in obesity.
A high fat diet (for 20 weeks) does not change sEH expression, but elevates sEH activity
[37]. Inhibition of sEH, which decreased the degradation of EETs, decreased inflammation
and lowered lipid accumulation [38]. Our results also suggest that sEH knockout mice have
a significant body weight reduction that is associated with an increase in EETs levels (Fig.
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7). We also observed a decrease of the inflammatory cytokines NOV and TNF-α when
compared to WT mice. Taking all of the above information together with a decrease in
adipogenesis, paralleled by a decrease in size of adipocytes, decreased levels of sEH could
offer a favorable clinical approach for the treatment of obesity and associated metabolic
disorders.

Author Manuscript

sEH is upregulated in obesity and diabetes and is associated with a decrease of EETs levels
[39]. Increasing levels of EETs were associated with a reduction in adipocyte size in visceral
adipose tissue, and improved glucose tolerance and insulin sensitivity, and attenuation of
hypertension [23,28,40]. Furthermore, EETs have been shown to increase expression of
HO-1 in adipose tissue. HO-1-mediated antioxidant mechanisms can decrease levels of ROS
through increased levels of adiponectin [41]. The secretion of adiponectin is linked to
increased mitochondrial function, an increase in thermogenic genes, and inhibition of
adipogenesis [42].
Our previous studies indicated that upregulation of EETs can induce HO-1 expression and
HO activity [16,24,43]. EETs may activate NRF2, which leads to induction of HO-1. NRF2
activates several antioxidant genes, including HO-1 (as reviewed in [44]).
CoPP-mediated induction of HO-1 attenuated inflammatory markers and hypertension,
decreased circulating free fatty acids and C-reactive protein and increased adiponectin
through the activation of the AMPK-P13K- eNOS pathway [45]. Furthermore, based on our
study, in sEH KO mice after CoPP administration exhibited in higher EETs levels, which
illustrates the connection between HO-1 and EETs. These results are in agreement with our
previous results that showed that the beneficial effects of EETs prevented in the presence of
an tin mesoporphyrin (SnMP), an inhibitor of HO-activity [36].
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HO-1, which is an antioxidant, decreased superoxide anions in both aorta and adipocyte
tissue. It should be noted that HO-1-mediated antioxidant mechanism decreased levels of
ROS with increased levels of adiponectin, which when secreted from adipocytes, can
improve insulin action and reduce atherosclerotic processes [46]. The secretion of
adiponectin is linked to mitochondrial function, and exerts anti-hyperglycemic effect [42]. In
this study, we show that the level of adiponectin in sEH KO mice increased, indicating that
there is an increase in brown-like cell in the fat, associated with a decrease of oxidative
stress and inflammation and an increases in mitochondrial and thermogenic gene.
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The third key finding is that inhibition of sEH could prevent adipocyte differentiation, which
can moderately decrease ROS and inflammation and lead to an increase in mitochondrial
function. However, when coupled with increased levels of HO-1, ROS and inflammation are
fully attenuated. ROS are mostly generated from the mitochondrial respiratory chain, and
reduce molecular oxygen to form the superoxide anion [47], which decreased dramatically
in sEH KO mice and more dramatically after administration of CoPP. We also found that the
level of Mfn1 increased while Mfn2 was unchanged in sEH KO mice in adipose tissue.
Furthermore, there was an increase of COX-1 in the adipose tissue of KO mice, which marks
an increase in mitochondrial function. Adaptive thermogenesis and mitochondrial function
are correlated to adipocyte differentiation, and UCP-1 was also significantly upregulated in
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sEH KO mice. All the results in our study demonstrated the positive effect of sEH inhibition
in the reduction of inflammatory markers and decrease in ROS, which, in tur, could redirect
more white fat into beige (brown) like fat.
From a clinical perspective, ablation of sEH expression increased beige fat over white fat
through an increase in mitochondrial integrity and HO-1-adiponectin levels. Our study
suggests that sEH inhibition can suppress adipogenesis in adipose tissue, prevent adipogenic
lineage, furthermore the EETs-HO system participates in the regulation of the level of
inflammation and ROS formation, so as to ameliorate associated diseases such as obesity,
diabetes, cardiovascular disease. Hence, inhibition of sEH could be a novel pharmacologic
therapeutic approach to prevent and even reverse obesity and associated metabolic disorders.
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Effect of EETs and sEH inhibition on oil droplets formation in MSCs derived adipocytes.
We measured the effect of EETs administration and suppression of sEH on adipogenesis.
Daily supplementation of 11, 12-, and 14, 15-EETs was effective on adipogenesis
suppression at 14 days. Inhibition of sEH with AUDA, showed a significant (p < 0.05) and
synergistic reduction of lipid droplets formation in MSC-derived adipocytes. (n = 4), #p <
0.05 vs. control, ** p < 0.05 vs. control.
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Effect of sEH deletion on oil droplet formation. Ablation of sEH significantly (p < 0.05)
decreased lipid droplets size in MSC derived adipocytes. The percentage of cells with
morphological lipid droplets decreased following silencing sEH. The effect of siRNA on
adipogenesis was determined by counting cells with lipid droplets in the cytoplasm and cells
positive for the lipid-specific dye. The adipocyte cell size in the absence of siRNA was ±
pixels compared with ± pixels in the presence of siRNA. (n = 4), #p < 0.05 vs. control.
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Effect of sEH knockout on Inflammatory Cytokine levels in adipose tissue and
mitochondria. RT_PCR analysis showed significant (p < 0.05) increase in HO-1 mRNA
expression in adipose tissue of sEH KO mice as compared to WT control mice (Fig. 3A), the
mRNA expression of inflammatory cytokines such as NOV and TNFα were significantly
lower in sEH mice compared to control (Fig. 3B and 3C). These results indicate that
inhibition of sEH leads to HO-1 induction resulting in a decrease of inflammation. We
measured Mfn1 and 2 levels in adipose tissue of sEH KO mice. The results showed a
significant (p < 0.05) increase in Mfn1 mRNA expression in sEH KO mice compared to
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control. However, there is no significant change in Mfn2 expression (Fig. 3D and E).
Furthermore, levels of cytochrome c oxidase subunit I (COX-I) were significantly higher in
KO mice (Fig. 3F), and expression of FIS1 was not significantly different between groups
(Fig. 3G). Moreover, adiponectin mRNA expression significantly increased in sEH KO mice
(Fig. 3H and I). (n = 4), * p < 0.05 vs.WT.
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Effect of sEH knockout on Mitochondrial Function in aorta. In agreement with the results
from the fat tissue, we observed a significant (p < 0.05) increase in HO-1 (Fig. 4B) as well
as in Mfn1 (Fig. 4A) expression in the aortas of sEH KO mice as compared to control. These
results indicate that inhibition of sEH resulted in an increase in mitochondrial function.
Ablation of sEH and HO-1 induction significantly reduced superoxide anion formation in
aortas of mice compared to both KO sEH and WT control (Fig. 4C). (n = 4), * p < 0.05
vs.WT, #p < 0.05 vs sEH KO.
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Effect of sEH ablation with and without HO-1 Inducer on Adiposity. Deletion of sEH
decreased body weight in male null mice compared to control. Picture of mice indicated that
sEH KO mice are leaner than control group (Fig. 5A). Body weight of KO mice were 28.8
± 7.28 g compared with 36.17 ± 0.77 g of control mice (Fig. 5B). To further increase the
antioxidant functions of EETs, we treated sEH KO mice with a well-known HO-1 inducer
(CoPP). Western blot analysis showed significant (p < 0.05) increase in HO-1 protein
expression in adipose tissue of sEH KO mice as compared to WT control mice, this increase
was even more significant when CoPP treatment was given to sEH KO mice (Fig. 5C).The
body weight in sEH null mice was similar to sEH + CoPP group. (n = 4), * p < 0.05 vs.WT,
#p < 0.05 vs sEH KO.
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Effect of sEH ablation and HO-1 induction on EETs levels. The levels of isoforms of EETs
(5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) and the total EETs (2.32 ± 0.22 mg vs. 0.61
± 0.06 mg) levels were significantly (p < 0.05) increased in sEH KO mice compared to
control mice. Since not all EETs are released as functional EETs, we decided to inject CoPP,
a potent HO-1 inducer, to KO mice. As a result, we observed that administration of CoPP
lead to a significant increase in all forms of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15EET) as well as total EETs levels compared to control mice and sEH KO without CoPP (Fig.
6A–F) (n = 4), * p < 0.05 vs.WT male, #p < 0.05 vs sEH (−/−) male.
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Schematic Representation of the Effect of EET and HO-1 on ROS, mitochondrial function
and thermogenesis. AA-derived epoxides (Epoxyeicosatrienoic acid, EET) through CYP
pathway could rapidly degrade EET into less active DHET by soluble epoxide hydrolase
(sEH), and inhibitions of sEH could upregulate EET concentration and induce HO-1 activity.
Stem cell derived small adipocytes turned into large adipocyte with the upregulated level of
inflammation and ROS with mitochondrial dysfunction, while EET-HO correlated with
decreased inflammation and reduce ROS, paralleled by the size decrease of adipocytes to
prevent adipocyte differentiation. EET and HO-1 could also improve mitochondrial function
by upregulating Mfn1 and COX-1, associated with an adaptive thermogenesis. All these
benefits will result in to ameliorate adipocyte associated diseases such as obesity and
cardiovascular diseases.
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